配色: 字号:
6 Clinicopathological characteristics of vascular endothelial growth factor expression in uveal melanoma A meta‑analysis(1)
2021-12-07 | 阅:  转:  |  分享 
  
YANGetal:CLINICOPATHOLOGICALCHARACTERISTICSOFVEGFEXPRESSIONINUVEALMELANOMA
368
6.MusumeciF,RadiM,BrulloCandSchenoneS:Vascular17.SchwarzMAandCleaverOB:Developmentofthepulmonary
endothelialgrowthfactor(VEGF)receptors:drugsandnewendotheliumindevelopmentofthepulmonarycirculation:vascu-
inhibitors.JMedChem55:10797-10822,2012.logenesisandangiogenesis.In:ThePulmonaryEndothelium:
7.ErdeiEandTorresSM:AnewunderstandingintheepidemiologyFunctioninHealthandDisease.VoelkelNFandRoundsS(eds).
ofmelanoma.ExpertRevAnticancerTher10:1811-1823,2010.1stedition.Wiley-Blackwell,Chichester,pp3-24,2009.
8.ElFilaliM,vanderVeldenPA,LuytenGPandJagerMJ:18.DingGX,FengCC,SongNH,etal:Paraneoplasticsymptoms:
Anti-angiogenictherapyinuvealmelanoma.DevOpthalmol49:Cachexia,polycythemia,andhypercalcemiaare,respectively,
117-136,2012.relatedtovascularendothelialgrowthfactor(VEGF)expression
9.SpagnoloF,CaltabianoGandQueiroloP:Uvealmelanoma.inrenalclearcellcarcinoma.UrolOncol:Apr23,2012(Epub
CancerTreatRev38:549-553,2012.aheadofprint).
10.FrancoR,BottiG,MascoloM,etal:CXCR4-CXCL12and19.UgurelS,RapplG,TilgenWandReinholdU:Increasedserum
VEGFcorrelatetouvealmelanomaprogression.FrontBiosciconcentrationofangiogenicfactorsinmalignantmelanoma
(EliteEd)2:13-21,2010.patientscorrelateswithtumorprogressionandsurvival.JClin
11.BerseB,BrownLF,VanDeWaterL,DvorakHFandSengerDR:Oncol19:577-583,2001.
Vascularpermeabilityfactor(vascularendothelialgrowthfactor)20.ClarijsR,SchalkwijkL,RuiterDJanddeWaalRM:Lackof
geneisexpresseddifferentiallyinnormaltissues,macrophages,lymphangiogenesisdespitecoexpressionofVEGF-Candits
andtumors.MolBiolCell3:211-220,1992.receptorFlt-4inuvealmelanoma.InvestOphthalmolVisSci42:
12.StittAW,SimpsonDA,BoocockC,GardinerTA,MurphyGM1422-1428,2001.
andArcherDB:Expressionofvascularendothelialgrowthfactor21.BoydSR,TanDS,deSouzaL,etal:Uvealmelanomasexpress
(VEGF)anditsreceptorsisregulatedineyeswithintra-ocularvascularendothelialgrowthfactorandbasicfibroblastgrowth
tumours.JPathol186:306-312,1998.factorandsupportendothelialcellgrowth.BrJOphthalmol86:
13.SheidowTG,HooperPL,CrukleyC,YoungJandHeathcoteJG:440-447,2002.
Expressionofvascularendothelialgrowthfactorinuveal22.WangFH,LiB,SunXL,etal:Correlationoftumorangiogenesis
melanomaanditscorrelationwithmetastasis.BrJOphthalmol84:withclinicopathologicprognosticparametersinchoroidal
750-756,2000.melanoma.ChinJOphthalmol39:68-72,2003(InChinese).
14.PerroneG,SantiniD,VincenziB,ZagamiM,LaCesaA,23.SahinA,KiratliH,TezelGG,SoylemezogluFandBilgicS:
BianchiA,AltomareV,PrimaveraA,BattistaC,VetraniA,ExpressionofvascularendothelialgrowthfactorA,matrix
ToniniGandRabittiC:COX-2expressioninDCIS:corre-metalloproteinase9andextravascularmatrixpatternsinirisand
lationwithVEGF,HER-2/neu,prognosticmolecularmarkersciliarybodymelanomas.OphthalmicRes39:40-44,2007.
andclinicopathologicalfeatures.Histopathology46:561-568,24.ZhaoXJ,LiB,LiLQ,GaoFandSunXL:Relationshipof
2005.survivinandVEGFwithangiogenesisinchoroidalmelanoma.
15.SchoriH,KipnisJ,YolesE,WoldeMussieE,RuizG,WheelerChinOphthalRes27:770-773,2009(InChinese).
LAandSchwartzM:Vaccinationforprotectionofretinal25.XuQ,ZhaoGQ,ZhaoJ,etal:Expressionandsignificanceof
ganglioncellsagainstdeathfromglutamatecytotoxicityandfactorsrelatedtoangiogenesisinchoroidalmelanoma.IntJ
ocularhypertension:implicationsforglaucoma.ProcNatlAcadOphthalmol4:49-54,2011.
SciUSA98:3398-3403,200126.PangX,YunhuiQandYueweM:ExpressionsofAdisintegrin
16.DamatoBE,PaulJandFouldsWS:Predictivefactorsofvisualandmetalloproteinase9andvascularendothelialgrowthfactor
outcomeafterlocalresectionofchoroidalmelanoma.BrJinocularmalignantmelanomas.RecAdvOphthalmol32:
Ophthalmol77:616-623,1993.620-623,2012(InChinese).
献花(0)
+1
(本文系皮肤科杨猛...首藏)